Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Alcidion Group Limited ( (AU:ALC) ) is now available.
Alcidion Group Limited has released its FY25 results, highlighting the company’s continued focus on leveraging technology to improve healthcare delivery. The announcement underscores the company’s commitment to providing advanced digital solutions that enhance healthcare operations, although it cautions stakeholders about the inherent uncertainties and risks associated with forward-looking statements and financial projections.
The most recent analyst rating on (AU:ALC) stock is a Hold with a A$0.13 price target. To see the full list of analyst forecasts on Alcidion Group Limited stock, see the AU:ALC Stock Forecast page.
More about Alcidion Group Limited
Alcidion Group Limited operates in the healthcare technology industry, providing innovative software solutions aimed at improving patient care and operational efficiencies in healthcare settings. Their primary products and services focus on healthcare analytics, patient flow management, and clinical decision support, targeting hospitals and healthcare providers to enhance their digital health capabilities.
Average Trading Volume: 1,304,886
Technical Sentiment Signal: Buy
Current Market Cap: A$134.3M
See more data about ALC stock on TipRanks’ Stock Analysis page.